GE HealthCare Technologies Gross Profit 2020-2025 | GEHC
GE HealthCare Technologies annual/quarterly gross profit history and growth rate from 2020 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- GE HealthCare Technologies gross profit for the quarter ending March 31, 2025 was $2.012B, a 5.84% increase year-over-year.
- GE HealthCare Technologies gross profit for the twelve months ending March 31, 2025 was $8.316B, a 4.84% increase year-over-year.
- GE HealthCare Technologies annual gross profit for 2024 was $8.205B, a 3.57% increase from 2023.
- GE HealthCare Technologies annual gross profit for 2023 was $7.922B, a 10.35% increase from 2022.
- GE HealthCare Technologies annual gross profit for 2022 was $7.179B, a 0.07% increase from 2021.
| GE HealthCare Technologies Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $8,205 |
| 2023 | $7,922 |
| 2022 | $7,179 |
| 2021 | $7,174 |
| 2020 | $6,767 |
| 2019 | $6,548 |
| GE HealthCare Technologies Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $2,012 |
| 2024-12-31 | $2,277 |
| 2024-09-30 | $2,025 |
| 2024-06-30 | $2,002 |
| 2024-03-31 | $1,901 |
| 2023-12-31 | $2,156 |
| 2023-09-30 | $1,935 |
| 2023-06-30 | $1,940 |
| 2023-03-31 | $1,891 |
| 2022-12-31 | $1,932 |
| 2022-09-30 | $1,773 |
| 2022-06-30 | $1,796 |
| 2022-03-31 | $1,678 |
| 2021-12-31 | |
| 2021-09-30 | |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $30.985B | $19.672B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||